NT-proBNP measurement is a key diagnostic tool for identifying individuals with left ventricular dysfunction. Changes in NT-proBNP levels can also be used to monitor the effectiveness of treatment in patients with heart failure or other forms of left ventricular impairment.
Unlike other tests, NT-proBNP levels are not influenced by therapy with Nesiritide (a synthetic form of BNP used to treat heart failure), ensuring reliable results even during treatment.
NT-proBNP is invaluable in differentiating between cardiac and pulmonary causes of dyspnea (shortness of breath), helping clinicians determine whether the underlying issue is heart-related or due to lung conditions.
Emerging evidence suggests that NT-proBNP may also play a role in assessing vascular remodeling, a process involved in conditions such as chronic heart failure, hypertension, and other cardiovascular diseases.